SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI
CCSI 22.38-4.8%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Lake who wrote (3904)7/2/1998 2:38:00 PM
From: Rajiv  Read Replies (1) of 5736
 
From briefing.com

14:22 ET Chromatics Color Sciences (CCSI) 5 7/32 +29/32: Stock benefitting from "buy" rating issued by Janssen/Myers Associates. Firm also called comments by Asensio & Co baseless. Says company has received FDA approval for product and should be joining a partner soon to bring the product to market. On June 9, Asensio & Co, a professional short-selling outfit, said that CCSI grossly exaggerated the market for its TLc-BiliTes, a product that tests infants for jaundice. At the time, the firm issued a "strong sell" recommendation on the stock, knocking the issue down several points. For more information on this story, see the Press Releases from the past month.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext